OOIR: Observatory of International Research

Papers

(The H4-Index of Psychopharmacology is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Acute analgesic effect of nicotine vaping using three experimental pain induction tasks: a randomized, placebo-controlled laboratory study	122
The effects of alcohol and co-witness information on memory reports: a field study	79
History of episodic heavy alcohol use predicts antidepressant effectiveness of ketamine	57
A cumulative Bayesian network meta-analysis on the comparative efficacy of pharmacotherapies for mania over the last 40 years	56
Does the smell of alcohol make it harder to resist? The impact of olfactory cues on inhibitory control and attentional bias	47
Prevalence of clozapine-induced sialorrhea and its effect on quality of life	47
Psychedelic-assisted psychotherapy: where is the psychotherapy research?	42
Effects of estrogen on spatial navigation and memory	41
Risky decision-making in the balloon analogue risk task – the role of noradrenaline and cortisol	37
(R)-Ketamine reduces alcohol intake and alcohol seeking induced by reconsolidation of alcohol-related memories in female Marchigian Sardinian alcohol-preferring rats	37
The beneficial effects of vortioxetine on BDNF, CREB, S100B, β amyloid, and glutamate NR2b receptors in chronic unpredictable mild stress model of depression	36
Association between angiotensin-converting enzyme gene insertion/deletion polymorphism and cognition impairment in patients with schizophrenia	34
Respiratory effects of oral mitragynine and oxycodone in a rodent model	32
Xylazine exacerbates fentanyl-induced respiratory depression and prevents rescue by naloxone in mice	32
An automated group-housed oral fentanyl self-administration method in mice	32
The impact of anti-craving medication on cue reactivity and abstinence in patients undergoing alcohol detoxification: some preliminary evidence from a retrospective event-related potentials study	31
Too big to fail? Comparing effect sizes of MDMA assisted therapy to unmasking bias	31
Allosteric inhibition of phosphodiesterase 4D induces biphasic memory-enhancing effects associated with learning-activated signaling pathways	30
Atypical antipsychotics attenuate MK801-induced social withdrawal and hyperlocomotion in the RHA rat model of schizophrenia-relevant features	30
Neural underpinnings of response inhibition in substance use disorders: weak meta-analytic evidence for a widely used construct	29
Desulfovibrio confers resilience to the comorbidity of pain and anxiety in a mouse model of chronic inflammatory pain	29
Reproductive experience modifies the dopaminergic system of postpartum estrous rats: changes in the sensitivity to the behavioural effects of sch-23390 and in its receptors' binding	29
Mechanisms underlying microRNA-222-3p modulation of methamphetamine-induced conditioned place preference in the nucleus accumbens in mice	29
L-Theanine adjunct to risperidone in the treatment of chronic schizophrenia inpatients: a randomized, double-blind, placebo-controlled clinical trial	29
Acute administration of ibuprofen increases serum concentration of the neuroprotective kynurenine pathway metabolite, kynurenic acid: a pilot randomized, placebo-controlled, crossover study	28

Effects of acute alcohol exposure and chronic alcohol use on neurite orientation dispersion and density imaging (NODDI) parameters	28
A systematic review of the role of clozapine for severe borderline personality disorder	27